Showing results (2821-2830 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|April 1, 1999
Short-term toxicity in pediatric marrow transplantation using related and unrelated donorsK Vettenranta, L Hovi, U M Saarinen-Pihkala
Bone Marrow Transplantation|April 1, 1999
Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitisA Srivastava, S C Nair, V M Srivastava, et al.
Bone Marrow Transplantation|April 1, 1999
Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescueS Bilgrami, N G Chakraborty, F Rodriguez-Pinero, et al.
Bone Marrow Transplantation|April 1, 1999
Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapseJ Serrano, J Román, C Herrera, et al.
Bone Marrow Transplantation|April 1, 1999
Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantationJ L Steegmann, L F Casado, J F Tomás, et al.
Bone Marrow Transplantation|April 1, 1999
Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo OsseoA Messori, A Bosi, S Bacci, et al.
Bone Marrow Transplantation|April 1, 1999
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezingD Cilloni, D Garau, E Regazzi, et al.
Bone Marrow Transplantation|April 1, 1999
Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHDA A Bhave, K Thirunavukkarasu, D J Gottlieb, et al.
Bone Marrow Transplantation|April 1, 1999
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myelomaH M Lokhorst, P Sonneveld, J J Cornelissen, et al.
Bone Marrow Transplantation|April 1, 1999
Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphomaM Bernard, C Dauriac, B Drénou, et al.
Pageof 993